Zoetis Inc. ZTS
Zoetis Inc. (NYSE: ZTS) is an animal health company.
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| Simparica / Simparica Trio | parasiticide, dogs | small molecule | Approved |
| Apoquel | allergic/atopic dermatitis, dogs | small molecule | Approved |
| Cytopoint | atopic dermatitis, dogs | antibody | Approved |
| Librela | osteoarthritis pain, dogs | antibody | Approved |
Recent results and decisions
- Aug 6, 2026approval FDA emergency use authorization for Dectomax for prevention of New World screwworm infestations in swine, sheep, deer, horses and dairy cattle.
together with Dectomax®, received emergency use authorization in the U.S. for prevention of infestations in swine, sheep, deer, horses, lactating and dry dairy cows, and dairy replacement heifers.
Filing - Aug 6, 2026approval US expanded label approval for Synovex One Grower for dry lots or pasture with insufficient forage.
Synovex® One Grower gained an expanded label approval in the U.S. to increase the rate of weight gain in growing beef steers and heifers in dry lots or on pasture with insufficient forage.
Filing - Aug 6, 2026approval European Commission marketing authorization for Poulvac Procerta HVT-ND (ex-US regulator).
In July, the company received marketing authorization from the European Commission for Poulvac® Procerta® HVT-ND.
Filing
2 more on record.
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.